文献速递其他结缔组织病

基线疾病活动度影响原发性干燥综合征患者后续达到患者可接受症状状态

Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究纵向评估115例原发性干燥综合征(pSS)患者的ESSPRI和ESSDAI等指标,中位随访3年,102例完成。结果显示ESSPRI、ClinESSDAI和EQ-5D保持稳定,PGA和ESSDAI显著改善;51.0%患者达到PASS,且与基线ESSPRI负相关(OR 0.609)、基线ESSDAI正相关(OR 1.224)。

要点

  • 基线ESSPRI较低和ESSDAI较高的pSS患者更易达到PASS。
  • 随访期间ESSPRI和ClinESSDAI保持稳定,PGA和ESSDAI显著改善。
  • 达到PASS的患者更常出现ESSPRI-MCII和mSSRI-30应答。

核心结论

  • 尽管pSS患者ESSPRI和ClinESSDAI纵向变化稳定,基线ESSPRI和ESSDAI可提供后续达到PASS的预后信息。

研究设计与样本

  • 研究纳入115例pSS患者,评估基线和随访时ESSPRI、ESSDAI、ClinESSDAI等指标,102例(88.7%)完成中位3年随访。

主要发现

  • 随访时ESSPRI、ClinESSDAI和EQ-5D水平保持稳定,PGA和ESSDAI显著改善(均P<0.05)。
  • 102例中52例(51.0%)达到PASS,且PASS组更常达到ESSPRI-MCII和mSSRI-30(均P<0.001)。
  • 多因素分析显示PASS与基线ESSPRI负相关(OR 0.609),与基线ESSDAI正相关(OR 1.224)。
  • 基线低ESSPRI和高ESSDAI亚组的PASS达成率为79.3%。

关键数值与推荐

  • PASS达成率51.0%;基线ESSPRI的OR为0.609,基线ESSDAI的OR为1.224;低ESSPRI高ESSDAI亚组PASS达成率79.3%。

临床怎么用

  • 可利用基线ESSPRI和ESSDAI对pSS患者达到PASS的可能性进行分层评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate longitudinal changes of the EULAR SS Patient-Reported Index (ESSPRI) and EULAR SS Disease Activity Index (ESSDAI), and identify factors associated with patient acceptable symptom state (PASS) in patients with primary SS (pSS). METHODS: We assessed ESSPRI, ESSDAI, clinical ESSDAI (ClinESSDAI), EULAR Sicca Score, EuroQoL 5-dimension (EQ-5D), Fatigue Severity Score, Beck Depression Inventory, and patient global assessment (PGA) for pSS, and visual analogue scale (VAS) scores for glandular and extra-glandular symptoms at baseline and follow-up. The responses to the currently available standards of care were evaluated by the PASS, the minimal clinically important improvement (MCII) of ESSPRI and ESSDAI, and a modified SS Responder Index-30 (mSSRI-30) response. RESULTS: Among 115 patients enrolled, 102 (88.7%) completed a median 3-year follow-up. The ESSPRI, ClinESSDAI and EQ-5D levels remained stable, although the PGA and ESSDAI significantly improved (both P <0.05). Of the 102 patients, 52 (51.0%) patients achieved the PASS at the follow-up and tended to attain the ESSPRI-MCII and mSSRI-30 (both P < 0.001) more frequently than the non-PASS group. Multivariate analysis revealed that the PASS was significantly associated with baseline ESSPRI negatively [odds ratio (OR) 0.609] and ESSDAI positively (OR 1.224). When categorized using baseline ESSPRI and ESSDAI, a subgroup of low ESSPRI and high ESSDAI reached a PASS achievement rate of 79.3%. CONCLUSION: Although longitudinal changes in ESSPRI and ClinESSDAI are stable in pSS, baseline ESSPRI and ESSDAI could provide prognostic information on the subsequent achievement of PASS, using currently available treatments. A categorization model using ESSPRI and ESSDAI may have clinical implications.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Park EH, Ha YJ, Kang EH, et al. Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome. Rheumatology (Oxford). 2021. PMID: 33188390. doi:10.1093/rheumatology/keaa687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。